RxDoctor Payments Data

William Thomas, MD

Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1952763021

Payments from drug & device makers

What this record shows

This record is dominated by education: $20,000 of the $27,479 with a category attached, or 72.8%. Smith+Nephew accounts for 73.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $10,342 and has fallen 55.5% since, to $4,601 in 2025.

$27,479in general payments, 2019–2025

Across 42 payments — averaging $654.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$20K
  • Medacta USA, Inc.$7K
  • Stryker$392
  • Think Surgical, Inc.$126
  • Johnson & Johnson$72
  • Fidia Pharma USA Inc.$21
  • plus $21 from 1 others

What the payments were for

  • Consulting fees$2,0007%
  • Travel & lodging$3,12811%
  • Food & beverage$2,3519%
  • Education$20,00073%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,479 in reported general payments places this provider in the 70th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$209,313
Medicare patients
401
Services billed
2,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin39$275
Amoxicillin14$37

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →